CAS NO: | 1361644-26-9 |
包装 | 价格(元) |
2mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 |
Aldoxorubicin (INNO-206) is an albumin-binding prodrug of Doxorubicin (DNAtopoisomeraseII inhibitor), which is released from albumin under acidic conditions. Aldoxorubicin (INNO-206) has potent antitumor activities in variouscancercell lines and in murine tumor models. |
||||||||||||||||
IC50& Target |
|
||||||||||||||||
体外研究 (In Vitro) |
Aldoxorubicin (INNO-206) (0.27 to 2.16 μM) inhibits blood vessel formation and reduces multiple myeloma cell growth in a pH-dependent fashion[1].
|
||||||||||||||||
体内研究 (In Vivo) |
Aldoxorubicin (INNO-206) (10.8 mg/kg, i.v.) shows significantly smaller tumor volumes and IgG levels on days 28, and is well tolerated with 90% of mice surviving until the termination of the study in the mice bearing the LAGκ-1A tumor[1]. Aldoxorubicin (INNO-206) shows a good safety profile at doses up to 260 mg/mL doxorubicin equivalents, and is able to induce tumor regressions in breast cancer, small cell lung cancer and sarcoma in phase I study[2]. Aldoxorubicin (INNO-206) shows superior activity over doxorubicin in a murine renal cell carcinoma model and in breast carcinoma xenograft models[3].
|
||||||||||||||||
Clinical Trial |
|
||||||||||||||||
分子量 |
750.75 |
||||||||||||||||
性状 |
Solid |
||||||||||||||||
Formula |
C37H42N4O13 |
||||||||||||||||
CAS 号 |
1361644-26-9 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
-80°C, stored under nitrogen *该半岛bd体育手机客户端 在溶液状态不稳定,建议您现用现配,即刻使用。 |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : ≥ 50 mg/mL(66.60 mM) *"≥" means soluble, but saturation unknown.
配制储备液
*
请根据半岛bd体育手机客户端 在不同溶剂中的溶解度,选择合适的溶剂配制储备液;该半岛bd体育手机客户端在溶液状态不稳定,建议您现用现配,即刻使用。
In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
*
以上所有助溶剂都可在本网站选购。
|